Information de reference pour ce titreAccession Number: | 00042819-201012006-00001.
|
Author: | Weiler, John M. MD, MBA; Anderson, Sandra D. PhD, DSc; Randolph, Christopher MD; Bonini, Sergio MD; Craig, Timothy J. DO; Pearlman, David S. MD; Rundell, Kenneth W. PhD, FACSM; Silvers, William S. MD; Storms, William W. MD; Bernstein, David I. MD; Blessing-Moore, Joann MD; Cox, Linda MD; Khan, David A. MD; Lang, David M. MD; Nicklas, Richard A. MD; Oppenheimer, John MD; Portnoy, Jay M. MD; Schuller, Diane E. MD; Spector, Sheldon L. MD; Tilles, Stephen A. MD; Wallace, Dana MD; Henderson, William MD; Schwartz, Lawrence MD, PhD; Kaufman, David MD; Nsouli, Talal MD; Shieken, Lawrence MD; Rosario, Nelson MD
|
Institution: | (a)President, CompleWare Corporation, Professor Emeritus, University of Iowa, Iowa City, Iowa (b)Clinical Professor, Sydney Medical School, Royal Prince Alfred Hospital, Department of Respiratory and Sleep Medicine, Camperdown NSW 2050, Australia (c)Clinical Professor of Pediatrics, Yale Affiliated Programs, Waterbury Hospital, Center for Allergy, Asthma and Immunology, Waterbury, Connecticut (d)Professor of Medicine, Chair Allergology and Clinical Immunology, Second University of Naples, Naples, Italy (e)Professor of Medicine and Pediatrics and Distinguished Educator, Pennsylvania State University, Hershey, Pennsylvania (f)Clinical Professor of Pediatrics, University of Colorado School of Medicine, Colorado Allergy and Asthma Centers, P.C., Denver, Colorado (g)Director of Respiratory Research & the Human Physiology Laboratory Center for Healthy Families, Marywood University Professor of the Basic Sciences, The Commonwealth Medical College, Scranton, Pennsylvania (h)Clinical Professor of Medicine, University of Colorado School of Medicine, Allergy, Asthma & Immunology Clinic of Colorado, P.C., Englewood, Colorado (i)Clinical Professor, University of Colorado Health Sciences Center, Practicing Allergist and Clinical Researcher, The William Storms Allergy Clinic, Colorado Springs, Colorado (j)Professor of Medicine and Environmental Health, Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine University of Cincinnati, Cincinnati, Ohio (k)Adjunct Clinical Professor, Department of Immunology, Stanford University Medical Center, Palo Alto, California (l)Associate Clinical Professor, Department of Medicine, Nova Southeastern University, Davie, Florida (m)Department of Medicine, Division of Allergy & Immunology, University of Texas Southwestern Medical Center, Dallas, Texas (n)Allergy/Immunology Section, Respiratory Institute, Cleveland Clinic Foundation, Cleveland, Ohio (o)Clinical Professor of Medicine, George Washington Medical Center, Washington, DC (p)Department of Internal Medicine, New Jersey Medical School, Morristown, New Jersey (q)Section of Allergy, Asthma & Immunology, The Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri (r)Professor of Pediatrics, Emeritus Chief of Allergy and Immunology, Department of Pediatrics, Pennsylvania State University, Milton S. Hershey Medical College, Hershey, Pennsylvania (s)Department of Medicine, UCLA School of Medicine, Los Angeles, California (t)Clinical Associate Professor of Medicine, University of Washington School of Medicine, Seattle, Washington (v)Seattle, Washington (w)Richmond, Virginia (x)Shreveport, Louisiana (y)Washington, DC (z)Owings Mills, Maryland (aa)Curitiba, Brazil (1)Chief Editor (2)Co-editor (3)Task Force Reviewer (4)Reviewer
|
Title: | Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter.[Miscellaneous Article]
|
Source: | Annals of Allergy, Asthma, & Immunology. 105 (Suppl. 6):S1-S47, December 2010.
|
References: | 1. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33:208-213. III.
2. Parsons JP, Kaeding C, Phillips G, Jarjoura D, Wadley G, Mastronarde JG. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. 2007;39:1487-1492. III.
3. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol. 2008;122:238-248. IV.
4. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol. 2002;110:374-380. IV.
5. Bye MR, Kerstein D, Barsh E. The importance of spirometry in the assessment of childhood asthma. Am J Dis Child. 1992;146:977-978. IV.
6. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309-329. IV.
7. Weiler JM, Bonini S, Coifman R, et al. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol. 2007;119:1349-1358. IV.
8. Koh MS, Tee A, Lasserson TJ, Irving LB. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database Syst Rev. 2007:CD002739. Ia.
9. Subbarao P, Duong M, Adelroth E, et al. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol. 2006;117:1008-1013. Ib.
10. Anderson SD, Kippelen P. Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes. J Allergy Clin Immunol. 2008;122:225-235. IV.
11. Hallstrand TS, Henderson WR Jr. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol. 2010;10:60-66. IV.
12. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is [horizontal ellipsis]. J Allergy Clin Immunol. 2000;106:453-459. IV.
13. Anderson SD, Holzer K. Exercise-induced asthma: is it the right diagnosis in elite athletes?. J Allergy Clin Immunol. 2000;106:419-428. IV.
14. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 2006;7:95-100. IV.
15. Hilberg T, Deigner HP, Moller E, et al. Transcription in response to physical stress-clues to the molecular mechanisms of exercise-induced asthma. FASEB J. 2005;19:1492-1494. IIa.
16. Hallstrand TS, Debley JS, Farin FM, Henderson WR Jr. Role of MUC5AC in the pathogenesis of exercise-induced bronchoconstriction. J Allergy Clin Immunol. 2007;119:1092-1098. IIb.
17. Carlsen KH, Engh G, Mork M. Exercise-induced bronchoconstriction depends on exercise load. Respir Med. 2000;94:750-755. III.
18. Cockcroft D, Davis B. Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol. 2009;103:363-369. IV.
19. Abu-Hasan M, Tannous B, Weinberger M. Exercise-induced dyspnea in children and adolescents: if not asthma then what?. Ann Allergy Asthma Immunol. 2005;94:366-371. IIb.
20. Weinberger M, Abu-Hasan M. Perceptions and pathophysiology of dyspnea and exercise intolerance. Pediatr Clin North Am. 2009;56:33-48. ix. III.
21. Grzelewski T, Stelmach I. Exercise-induced bronchoconstriction in asthmatic children: a comparative systematic review of the available treatment options. Drugs 2009;69(12):1533-1553. IV.
22. Carlsen KH, Anderson SD, Bjermer L, et al. Treatment of exercise induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN. Allergy 2008;63:492-505. IV.
23. Stelmach I, Grzelewski T, Majak P, Jerzynska J, Stelmach W, Kuna P. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol. 2008;121:383-389. Ib.
24. Raissy HH, Harkins M, Kelly F, Kelly HW. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children. Pharmacotherapy 2008;28:287-294. Ib.
25. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med. 1994;88:363-368. Ib.
26. Simons FE, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997;99:655-659. Ib.
27. Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med. 2005;99:566-571. IIa.
28. Weiler JM, Nathan RA, Rupp NT, Kalberg CJ, Emmett A, Dorinsky PM. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Ann Allergy Asthma Immunol. 2005;94:65-72. Ia.
29. Spooner CH, Spooner GR, Rowe BH. Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction. Cochrane Database Syst Rev. 2003;4:CD002307. Ia.
30. Kippelen P, Larsson J, Anderson SD, Brannan JD, Dahlen B, Dahlen SE. Effect of sodium cromoglycate on mast cell mediators during hyperpnea in athletes. Med Sci Sports Exerc. 2010;42:1853-1860. IIa.
31. Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. Pediatr Pulmonol. 2009;44:429-435. Ib.
32. Kippelen P, Larsson J, Anderson SD, et al. Acute effects of beclomethasone on hyperpnea-induced bronchoconstriction. Med Sci Sports Exerc. 2010;42:273-280. IIa.
33. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120(suppl 5):S94-S138. IV.
34. Mickleborough TD. A nutritional approach to managing exercise-induced asthma. Exerc Sport Sci Rev. 2008;36:135-144. Ib.
35. Fitch KD, Sue-Chu M, Anderson SD, et al. Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol. 2008;122:254-260. e1-7. IV.
36. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway response. Standardized provocation tests in adults: pharmacological, physical and sensitizing stimuli. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society.. Eur Respir J 1993;6(Supp 16):53-83. IV.
37. Godfrey S, Springer C, Bar-Yishay E, Avital A. Cut-off points defining normal and asthmatic bronchial reactivity to exercise and inhalation challenges in children and young adults. Eur Respir J 1999;14:659-668. Ia.
38. Kattan M, Keens TG, Mellis CM, Levison H. The response to exercise in normal and asthmatic children. J Pediatr. 1978;92:718-721. IIa.
39. Anderson SD, Charlton B, Weiler JM, et al. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res. 2009;10:4.:Ib.
40. Haby MM, Peat JK, Mellis CM, Anderson SD, Woolcock AJ. An exercise challenge for epidemiological studies of childhood asthma: validity and repeatability. Eur Respir J. 1995;8:729-736. IIa.
41. Hofstra WB, Neijens HJ, Duiverman EJ, et al. Dose-response over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol. 2000;29:415-423. IIb.
42. Jonasson G, Carlsen KH, Hultquist C. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren. Pediatr Allergy Immunol. 2000;11:120-125. Ib.
43. Niinimaa V, Cole P, Mintz S, Shephard RJ. The switching point from nasal to oronasal breathing. Respir Physiol. 1980;42:61-71. III.
44. Anderson SD, Togias A. Dry air and hyperosmolar challenge in asthma and rhinitis. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis, 2nd ed. Malden, MA: Blackwell Science Ltd; 1995:1449-1468. IV.
45. Anderson SD. Asthma provoked by exercise, hyperventilation, and the inhalation of non-isotonic aerosols. In: Barnes PJ, Rodger IW, Thomson NC, eds. Asthma: Basic Mechanisms and Clinical Management. 2nd ed. London, England: Academic Press Ltd; 1992:473-490. IV.
46. Bar-Or O, Neuman I, Dotan R. Effects of dry and humid climates on exercise-induced asthma in children and preadolescents. J Allergy Clin Immunol. 1977;60:163-168. IIa.
47. Chen WY, Horton DJ. Heat and water loss from the airways and exercise-induced asthma. Respiration 1977;34:305-313. IIb.
48. Strauss RH, McFadden ER Jr, Ingram RH Jr, Deal EC Jr, Jaeger JJ, Stearns D. Influence of heat and humidity on the airway obstruction induced by exercise in asthma. J Clin Invest. 1978;61:433-440. IIb.
49. Deal EC Jr, McFadden ER Jr, Ingram RH Jr, Jaeger JJ. Hyperpnea and heat flux: initial reaction sequence in exercise-induced asthma. J Appl Physiol. 1979;46:476-483. IIb.
50. McFadden ER Jr, Pichurko BM, Bowman HF, et al. Thermal mapping of the airways in humans. J Appl Physiol. 1985;58:564-570. IIb.
51. Daviskas E, Gonda I, Anderson SD. Local airway heat and water vapour losses. Respir Physiol. 1991;84:115-132. IV.
52. Anderson SD, Daviskas E, Schoeffel RE, Unger SF. Prevention of severe exercise-induced asthma with hot humid air. Lancet. 1979;2:(8143)629. IIb.
53. Anderson SD, Schoeffel RE, Follet R, Perry CP, Daviskas E, Kendall M. Sensitivity to heat and water loss at rest and during exercise in asthmatic patients. Eur J Respir Dis. 1982;63:459-471. IIb.
54. Silverman M, Anderson SD. Standardization of exercise tests in asthmatic children. Arch Dis Child. 1972;47:882-889. IIa.
55. Hallstrand TS, Bates PW, Schoene RB. Aerobic conditioning in mild asthma decreases the hyperpnea of exercise and improves exercise and ventilatory capacity. Chest 2000;118:1460-1469. IIa.
56. Shturman-Ellstein R, Zeballos RJ, Buckley JM, Souhrada JF. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis. 1978;118:65-73. IIb.
57. Schachter EN, Lach E, Lee M. The protective effect of a cold weather mask on exercise-induced asthma. Ann Allergy 1981;46:12-16. IIb.
58. Millqvist E, Bengtsson U, Lowhagen O. Combining a beta2-agonist with a face mask to prevent exercise-induced bronchoconstriction. Allergy 2000 Jul;55:672-675. IIb.
59. Daviskas E, Gonda I, Anderson SD. Mathematical modeling in heat and water transport in the human respiratory tract. J Appl Physiol. 1990;69:362-372. IV.
60. Siddiqui S, Mistry V, Doe C, et al. Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol. 2008;122:335-341. 341.e1-3. IIa.
61. Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J. 2002 May;19:879-885. IIa.
62. Freed AN, Davis MS. Hyperventilation with dry air increases airway surface fluid osmolality in canine peripheral airways. Am J Respir Crit Care Med. 1999;159:1101-1107. LB.
63. Gilbert IA, Fouke JM, McFadden ER Jr. Heat and water flux in the intrathoracic airways and exercise-induced asthma. J Appl Physiol. 1987;63:1681-1691. IIa.
64. McFadden ER Jr. Hypothesis: exercise-induced asthma as a vascular phenomenon. Lancet 1990;335(8694:880-883. IV.
65. McFadden ER Jr, Pichurko BM. Intraairway thermal profiles during exercise and hyperventilation in normal man. J Clin Invest. 1985;76:1007-1010. IIb.
66. McFadden ER Jr, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma: new insights into pathophysiology and possible pathogenesis. J Clin Invest. 1986;78:18-25. IIa.
67. Schoeffel RE, Anderson SD, Altounyan RE. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. Br Med J (Clin Res Ed) 1981;283:1285-1287. IIa.
68. Anderson SD. Is there a unifying hypothesis for exercise-induced asthma?. J Allergy Clin Immunol. 1984;73:660-665. IV.
69. Anderson SD, Schoeffel RE, Black JL, Daviskas E. Airway cooling as the stimulus to exercise-induced asthma-a re-evaluation. Eur J Respir Dis. 1985;67:20-30. IIa.
70. Hahn A, Anderson SD, Morton AR, Black JL, Fitch KD. A reinterpretation of the effect of temperature and water content of the inspired air in exercise-induced asthma. Am Rev Respir Dis. 1984;130:575-579. IIb.
71. Aitken ML, Marini JJ. Effect of heat delivery and extraction on airway conductance in normal and in asthmatic subjects. Am Rev Respir Dis. 1985;131:357-361. IIa.
72. Kivity S, Greif J, Reisner B, Fireman E, Topilsky M. Bronchial inhalation challenge with ultrasonically nebulized saline; comparison to exercise-induced asthma. Ann Allergy 1986;57:355-358. IIa.
73. Belcher NG, Rees PJ, Clark TJM, Lee TH. A comparison of the refractory periods induced by hypertonic airway challenge and exercise in bronchial asthma. Am Rev Respir Dis. 1987;135:822-825. IIb.
74. Boulet LP, Turcotte H. Comparative effects of hyperosmolar saline inhalation and exercise in asthma. Immunol Allergy Practice 1989;11:93-100. IIb.
75. Anderson SD, Daviskas E. The airway microvasculature and exercise-induced asthma. Thorax 1992;47:748-752. IV.
76. Ingenito E, Solway J, Lafleur J, Lombardo A, Drazen JM, Pichurko B. Dissociation of temperature-gradient and evaporative heat loss during cold gas hyperventilation in cold-induced asthma. Am Rev Respir Dis. 1988;138:540-546. IIb.
77. Argyros GJ, Phillips YY, Rayburn DB, Rosenthal RR, Jaeger JJ. Water loss without heat flux in exercise-induced bronchospasm. Am Rev Respir Dis. 1993;147:1419-1424. IIa.
78. Freed AN, Omori C, Hubbard WC, Adkinson NF. Dry air- and hypertonic aerosol-induced bronchoconstriction and cellular responses in the canine lung periphery. Eur Respir J. 1994;7:1308-1316. Ib.
79. Reiss TF, Hill JB, Harman E, et al. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:1030-1035. Ib.
80. O'Sullivan S, Roquet A, Dahlen B, et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J 1998;12:345-350. IIb.
81. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J. 2003;22:491-496. IIa.
82. Eggleston PA, Kagey-Sobotka A, Lichtenstein LM. A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis. 1987;135:1043-1048. Ib.
83. Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. Allergy 2006;61:1473-1479. Ib.
84. Moloney ED, Griffin S, Burke CM, Poulter LW, O'Sullivan S. Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus. Respir Med. 2003;97:928-932. LB.
85. Davis MS, Daviskas E, Anderson SD. Airway surface fluid desiccation during isocapnic hyperpnea. J Appl Physiol. 2003;94:2545-2546. LB.
86. Daviskas E, Anderson SD, Gonda I, Chan HK, Cook P, Fulton R. Changes in mucociliary clearance during and after isocapnic hyperventilation in asthmatic and healthy subjects. Eur Respir J. 1995;8:742-751. IIa.
87. Eschenbacher WL, Sheppard D. Respiratory heat loss is not the sole stimulus for bronchoconstriction induced by isocapnic hyperpnea with dry air. Am Rev Respir Dis. 1985;131:894-901. IIb.
88. Tabka Z, Ben Jebria A, Vergeret J, Guenard H. Effect of dry warm air on respiratory water loss in children with exercise-induced asthma. Chest 1988;94:81-86. IIa.
89. Chan-Yeung MM, Vyas MN, Grzybowski S. Exercise-induced asthma. Am Rev Respir Dis. 1971;104:915-923. IIb.
90. Kivity S, Souhrada JF. Hyperpnea: the common stimulus for bronchospasm in asthma during exercise and voluntary isocapnic hyperpnea. Respiration 1980;40:169-177. IIb.
91. Phillips YY, Jaeger JJ, Laube BL, Rosenthal RR. Eucapnic voluntary hyperventilation of compressed gas mixture. A simple system for bronchial challenge by respiratory heat loss. Am Rev Respir Dis. 1985;131:31-35. IIa.
92. Eliasson AH, Phillips YY, Rajagopal KR, Howard RS. Sensitivity and specificity of bronchial provocation testing. An evaluation of four techniques in exercise-induced bronchospasm. Chest 1992;102:347-355. IIa.
93. Mannix ET, Manfredi F, Farber MO. A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters. Chest 1999;115:649-653. IIb.
94. Rundell KW, Anderson SD, Spiering BA, Judelson DA. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest 2004;125:909-915. IIb.
95. Pedersen L, Winther S, Backer V, Anderson SD, Larsen KR. Airway responses to eucapnic hyperpnea, exercise and methacholine in elite swimmers. Med Sci Sports Exerc. 2008;40:1567-1572. IIb.
96. Dickinson J, McConnell A, Whyte G. Diagnosis of exercise-induced bronchoconstriction: eucapnic voluntary hyperpnoea challenges identify previously undiagnosed elite athletes with exercise-induced bronchoconstriction. Br J Sports Med. 2010;Jul 20. [Epub ahead of print]. IIb.
97. Argyros GJ, Roach JM, Hurwitz KM, Eliasson AH, Phillips YY. Eucapnic voluntary hyperventilation as a bronchoprovocation technique: development of a standardized dosing schedule in asthmatics. Chest 1996;109:1520-1524. III.
98. Hurwitz KM, Argyros GJ, Roach JM, Eliasson AH, Phillips YY. Interpretation of eucapnic voluntary hyperventilation in the diagnosis of asthma. Chest 1995;108:1240-1245. IIa.
99. Carlsen KH, Anderson SD, Bjermer L, et al. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 2008;63:387-403. IV.
100. Yoshikawa T, Shoji S, Fujii T, et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J. 1998;12:879-884. IIb.
101. Kivity S, Argaman A, Onn A, et al. Eosinophil influx into the airways in patients with exercise-induced asthma. Respir Med. 2000;94:1200-1205. IIa.
102. Gauvreau GM, Ronnen GM, Watson RM, O'Byrne PM. Exercise-induced bronchoconstriction does not cause eosinophilic airway inflammation or airway hyperresponsiveness in subjects with asthma. Am J Respir Crit Care Med. 2000;162:1302-1307. Ia.
103. Duong M, Subbarao P, Adelroth E, et al. Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest 2008;133:404-411. III.
104. Lee SY, Kim HB, Kim JH, et al. Eosinophils play a major role in the severity of exercise-induced bronchoconstriction in children with asthma. Pediatr Pulmonol. 2006;41:1161-1166. IIa.
105. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol. 1995;95(1 pt 1):29-33. Ib.
106. Thio BJ, Slingerland GL, Nagelkerke AF, Roord JJ, Mulder PGH, Dankert-Roelse JE. Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study. Pediatr Pulmonol. 2001;32:115-121. IIa.
107. Patel KR. Terfenadine in exercise-induced asthma. Br Med J (Clin Res Ed) 1984;288:1496-1497. Ib.
108. Tullett WM, Tan KM, Wall RT, Patel KR. Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma. Thorax 1985;40:41-44. Ib.
109. Oseid S, Mellbye E, Hem E. Effect of nedocromil sodium on exercise-induced bronchoconstriction exacerbated by inhalation of cold air. Scand J Med Sci Sports 1995;5:88-93. Ib.
110. Baki A, Orhan F. The effect of loratadine in exercise-induced asthma. Arch Dis Child 2002;86:38-39. Ib.
111. Kelly KD, Spooner CH, Rowe BH. Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review. Eur Respir J 2001;17:39-45. Ia.
112. Pearlman DS, van Adelsberg J, Philip G, et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol. 2006;97:98-104. Ia.
113. Dahlen B, Roquet A, Inman MD, et al. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. J Allergy Clin Immunol. 2002;109(5 pt 1):789-793. Ib.
114. Rundell KW, Spiering BA, Baumann JM, Evans TM. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise. Br J Sports Med. 2005;39:232-236. Ib.
115. Nagakura T, Obata T, Shichijo K, et al. GC/MS analysis of urinary excretion of 9[alpha],11[beta]PGF2 in acute and exercise-induced asthma in children. Clin Exp Allergy 1998;28:181-186. Ib.
116. Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR Jr, Aitken ML. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 2005;172:679-686. Ib.
117. Haverkamp HC, Dempsey JA, Pegelow DF, et al. Treatment of airway inflammation improves exercise pulmonary gas exchange and performance in asthmatic subjects. J Allergy Clin Immunol. 2007;120:39-47. Ib.
118. Patel KR, Berkin KE, Kerr JW. Dose-response study of sodium cromoglycate in exercise-induced asthma. Thorax 1982;37:663-666. IIa.
119. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis. 1984;130:86-91. LB.
120. Van Rensen EL, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction: the role of substance P and neurokinin A in patients with asthma. Am J Respir Crit Care Med. 2002;165:1275-1279. IIb.
121. Hartley JP, Charles TJ, Monie RD, et al. Arterial plasma histamine after exercise in normal individuals and in patients with exercise-induced asthma. Clin Sci (Lond) 1981;61:151-157. IIa.
122. Anderson SD, Bye PTP, Schoeffel RE, Seale JP, Taylor KM, Ferris L. Arterial plasma histamine levels at rest, during and after exercise in patients with asthma: effects of terbutaline aerosol. Thorax 1981;36:259-267. IIa.
123. Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J. 2006;27:944-950. IIa.
124. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med. 1998;339:147-152. Ib.
125. Anderson SD, Brannan JD. Exercise induced asthma: is there still a case for histamine?. J Allergy Clin Immunol. 2002;109(5 pt1):771-773. IV.
126. Kanazawa H, Asai K, Hirata K, Yoshikawa J. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 2002;122:166-170. IIa.
127. Kanazawa H, Hirata K, Yoshikawa J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 2002;57:885-888. IIa.
128. Kanazawa H, Tochino Y, Asai K. Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy. J Allergy Clin Immunol. 2008;121:390-395. LB.
129. Edmunds AT, Tooley M, Godfrey S. The refractory period after exercise-induced asthma: its duration and relation to the severity of exercise. Am Rev Respir Dis. 1978;117:247-254. IIb.
130. Schoeffel RE, Anderson SD, Gillam I, Lindsay DA. Multiple exercise and histamine challenge in asthmatic patients. Thorax 1980;35:164-170. IIb.
131. Anderson SD, Schoeffel RE. Respiratory heat and water loss during exercise in patients with asthma. Effect of repeated exercise challenge. Eur J Respir Dis. 1982;63:472-480. IIb.
132. Larsson J, Perry CP, Brannan JD, Anderson SD, Dahlen SE, Dahlen B. Mast cell mediator release during refractoriness to mannitol induced bronchoconstriction. Eur Respir J. 2009;34:1978. IIa.
133. O'Byrne PM, Jones GL. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am Rev Respir Dis. 1986;134:69-72. IIa.
134. Margolskee DJ, Bigby BG, Boushey HA. Indomethacin blocks airway tolerance to repetitive exercise but not to eucapnic hyperpnea in asthmatic subjects. Am Rev Respir Dis. 1988;137:842-846. IIa.
135. Wilson BA, Bar-Or O, Seed LG. Effects of humid air breathing during arm or treadmill exercise on exercise-induced bronchoconstriction and refractoriness. Am Rev Respir Dis. 1990;142:349-352. IIb.
136. Wilson BA, Bar-Or O, O'Byrne PM. The effects of indomethacin on refractoriness following exercise both with and without bronchoconstriction. Eur Respir J. 1994;7:2174-2178. IIa.
137. Torres-Galvan SM, Cumplido JA, Buset N, et al. 5-Lipoxygenase pathway gene polymorphisms: lack of association with asthma in a Spanish population. J Investig Allergol Clin Immunol. 2009;19:453-458. IIa.
138. Kang MJ, Lee SY, Kim HB, et al. Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction. Pharmacogenet Genomics 2008;18:551-558. III.
139. Fahy JV. Goblet cell and mucin gene abnormalities in asthma. Chest 2002;122(suppl 6):320S-326S. IV.
140. Hallstrand TS, Wurfel MM, Lai Y, et al. Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes. PLoS One 2010;5:e8583. IIa.
141. Hallstrand TS, Chi EY, Singer AG, Gelb MH, Henderson WR Jr. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2007;176:1072-1078. IIa.
142. Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol. 2008;122:456-468. IV.
143. Barreto M, Villa MP, Olita C, Martella S, Ciabattoni G, Montuschi P. 8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. Chest 2008;135:66-73. IIb.
144. Rundell KW, Slee JB, Caviston R, Hollenbach AM. Decreased lung function after inhalation of ultrafine and fine particulate matter during exercise is related to decreased total nitrate in exhaled breath condensate. Inhal Toxicol. 2008;20:1-9. IIa.
145. Hazucha MJ, Folinsbee LJ, Bromberg PA. Distribution and reproducibility of spirometric response to ozone by gender and age. J Appl Physiol. 2003;95:1917-1925. III.
146. Folinsbee LJ, Horstman DH, Kehrl HR, Harder S, Abdul-Salaam S, Ives PJ. Respiratory responses to repeated prolonged exposure to 0.12 ppm ozone. Am J Respir Crit Care Med. 1994;149:98-105. IIb.
147. Horvath SM, Gliner JA, Folinsbee LJ. Adaptation to ozone: duration of effect. Am Rev Respir Dis. 1981;123:496-499. IIb.
148. McDonnell WF, Horstman DH, Hazucha MJ, et al. Pulmonary effects of ozone exposure during exercise: dose-response characteristics. J Appl Physiol. 1983;54:1345-1352. IIb.
149. Ercan H, Birben E, Dizdar EA, et al. Oxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma. J Allergy Clin Immunol. 2006;118:1097-1104. III.
150. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res. 1999;31:273-300. LB.
151. Islam T, Berhane K, McConnell R, et al. Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax 2009;64:197-202. III.
152. Ware JH. Particulate air pollution and mortality-clearing the air. N Engl J Med. 2000;343:1798-1799. IV.
153. Werz O, Szellas D, Steinhilber D. Reactive oxygen species released from granulocytes stimulate 5-lipoxygenase activity in a Blymphocytic cell line. Eur J Biochem. 2000;267:1263-1269. LB.
154. Atkinson RW, Anderson HR, Sunyer J, et al. Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med. 2001;164(10 pt 1):1860-1866. IV.
155. Tolbert PE, Mulholland JA, MacIntosh DL, et al. Air quality and pediatric emergency room visits for asthma in Atlanta, Georgia, USA. Am J Epidemiol. 2000;151:798-810. III.
156. Hiltermann TJ, Stolk J, van der Zee SC, et al. Asthma severity and susceptibility to air pollution. Eur Respir J. 1998;11:686-693. IV.
157. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, et al. Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med. 2007;357:2348-2358. IIb.
158. Rundell KW. High levels of airborne ultrafine and fine particulate matter in indoor ice arenas. Inhal Toxicol. 2003;15:237-250. III.
159. Rundell K. Pulmonary function decay in women ice hockey players: is there a relationship to ice rink air quality?. Inhal Toxicol. 2004;16:117-123. IIa.
160. Rundell KW, Spiering BA, Evans TM, Baumann JM. Baseline lung function, exercise-induced bronchoconstriction, and asthma-like symptoms in elite women ice hockey players. Med Sci Sports Exerc. 2004;36:405-410. III.
161. Rundell KW, Caviston R, Hollenbach AM, Murphy K. Vehicular air pollution, playgrounds, and youth athletic fields. Inhal Toxicol. 2006;18:541-547. IIb.
162. Mannix ET, Farber MO, Palange P, Galassetti P, Manfredi F. Exercise-induced asthma in figure skaters. Chest 1996;109:312-315. IIa.
163. Provost-Craig MA, Arbour KS, Sestili DC, Chabalko JJ, Ekinci E. The incidence of exercise-induced bronchospasm in competitive figure skaters. J Asthma 1996;33:67-71. III.
164. Wilber RL, Rundell KW, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic Winter Sport athletes. Med Sci Sports Exerc. 2000;32:732-737. IIb.
165. Anderson SD, Fitch K, Perry CP, et al. Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics. J Allergy Clin Immunol. 2003;111:45-50. III.
166. Rundell KW, Spiering BA, Baumann JM, Evans TM. Bronchoconstriction provoked by exercise in a high-particulate-matter environment is attenuated by montelukast. Inhal Toxicol. 2005;17:99-105. Ib.
167. Singh P, Madden M, Gilmour MI. Effects of diesel exhaust particles and carbon black on induction of dust mite allergy in brown Norway rats. J Immunotoxicol. 2005;2:41-49. LB.
168. Rabinovitch N, Strand M, Stuhlman K, Gelfand EW. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol. 2008;121:1365-1371. Ib.
169. Anderson SD, Sue-Chu M, Perry CP, et al. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics. J Allergy Clin Immunol. 2006;117:767-773. III.
170. Larsson K, Ohlsen P, Larsson L, Malmberg P, Rydstrom P-O, Ulriksen H. High prevalence of asthma in cross country skiers. BMJ 1993;307:1326-1329. IIa.
171. Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med. 1998;32:125-129. III.
172. Davis MS, Lockard AJ, Marlin DJ, Freed AN. Airway cooling and mucosal injury during cold weather exercise. Equine Vet J Suppl. 2002;34:413-416. LB.
173. Davis MS, Schofield B, Freed AN. Repeated peripheral airway hyperpnea causes inflammation and remodeling in dogs. Med Sci Sports Exerc. 2003;35:608-616. LB.
174. Helenius IJ, Tikkanen HO, Haahtela T. Association between type of training and risk of asthma in elite athletes. Thorax 1997;52:157-160. III.
175. Helenius I, Tikkanen HO, Helenius M, Lumme A, Remes V, Haahtela T. Exercise-induced changes in pulmonary function of healthy, elite long-distance runners in cold air and pollen season exercise challenge tests. Int J Sports Med. 2002;23:252-261. III.
176. Anderson SD, Kippelen P. Exercise-induced bronchoconstriction: pathogenesis. Curr Allergy Asthma Rep. 2005;5:116-122. IV.
177. Bjermer L, Anderson SD. Bronchial hyperresponsiveness in athletes; mechanisms for development. In: Carlsen K-H, Delgado L, Del Giacco S, eds. Diagnosis, Prevention and Treatment of Exercise-Related Asthma, Respiratory and Allergic Disorders in Sports. Wakefield, England: European Respiratory Society; IV.2005:2005-2034.
178. Stensrud T, Mykland KV, Gabrielsen K, Carlsen KH. Bronchial hyperresponsiveness in skiers: field test versus methacholine provocation?. Med Sci Sports Exerc. 2007;39:1681-1686. IIb.
179. Freed AN, Omori C, Schofield BH, Mitzner W. Dry air-induced mucosal cell injury and bronchovascular leakage in canine peripheral airways. Am J Respir Cell Mol Biol. 1994;11:724-732. LB.
180. Johnson PR, Ammit AJ, Carlin SM, Armour CL, Caughey GH, Black JL. Mast cell tryptase potentiates histamine induced contraction in human sensitized bronchus. Eur Respir J. 1996;10:38-43. LB.
181. Anticevich SZ, Hughes JM, Black JL, Armour CL. Induction of human airway hyperresponsiveness by tumor necrosis factor-alpha. Eur J Pharmacol. 1995;284:221-225. LB.
182. Anticevich SZ, Hughes JM, Black JL, Armour CL. Induction of hyperresponsiveness in human airway tissue by neutrophils-mechanism of action. Clin Exp Allergy 1996;26:549-556. IV.
183. Ammit AJ, Bekir SS, Johnson PR, Hughes JM, Armour CL, Black JL. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am J Respir Crit Care Med. 1997;155:1123-1129. LB.
184. Sue-Chu M, Larsson L, Bjermer L. Prevalence of asthma in young cross-country skiers in central Scandinavia: differences between Norway and Sweden. Respir Med. 1996;90:99-105. IIb.
185. Leuppi JD, Kuhn M, Comminot C, Reinhart WH. High prevalence of bronchial hyperresponsiveness and asthma in ice hockey players. Eur Respir J. 1998;12:13-16. IIb.
186. Sue-Chu M, Brannan JD, Anderson SD, Chew N, Bjermer L. Airway hyperresponsiveness to methacholine, adenosine 5-monophosphate, mannitol, eucapnic voluntary hyperpnea and field exercise challenge in elite cross country skiers. Brit J Sports Med. 2010;44:827-832. IIb.
187. Hemingson HB, Davis BE, Cockcroft DW. Seasonal fluctuations in airway responsiveness in elite endurance athletes. Can Respir J. 2004;1:399-401. IIb.
188. Helenius I, Rytila P, Sarna S, et al. Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: a 5-year prospective follow-up study of 42 highly trained swimmers. J Allergy Clin Immunol. 2002;109:962-968. IIb.
189. Caillaud C, Le Creff C, Legros P, Denjean A. Strenuous exercise increases plasmatic and urinary leukotriene E4 in cyclists. Can J Appl Physiol. 2003;28:793-806. IIa.
190. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006;117:1277-1284. LB.
191. Greiff L, Wollmer P, Andersson M, Svensson C, Persson CG. Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax 1998;53:1010-1013. IIa.
192. Scola AM, Chong LK, Suvarna SK, Chess-Williams R, Peachell PT. Desensitisation of mast cell [beta]2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol. 2004;141:163-171. LB.
193. Chong LK, Suvarna K, Chess-Williams R, Peachell PT. Desensitization of [beta]2-adrenoceptor-mediated responses by short-acting [beta]2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol. 2003;138:512-520. LB.
194. Mak JC, Roffel AF, Katsunuma T, Elzinga CR, Zaagsma J, Barnes PJ. Up-regulation of airway smooth muscle histamine H1 receptor mRNA, protein, and function by beta 2-adrenoceptor activation. Mol Pharmacol. 2000;57:857-864. LB.
195. McGraw DW, Elwing JM, Fogel KM, et al. Cross talk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest. 2007;117:1391-1398. LB.
196. Heir T, Aanestad G, Carlsen KH, Larsen S. Respiratory tract infection and bronchial responsiveness in elite athletes and sedentary control subjects. Scand J Med Sci Sports 1995;5:94-99. IIa.
197. Nieman DC, Henson DA, Fagoaga OR, et al. Change in salivary IgA following a competitive marathon race. Int J Sports Med. 2002;23:69-75. IIa.
198. Sue-Chu M, Karjalainen EM, Altraja A, et al. Lymphoid aggregates in endobronchial biopsies from young elite cross-country skiers. Am J Respir Crit Care Med. 1998;158:597-601. IIa.
199. Delventhal S, Hensel A, Petzoldt K, Pabst R. Effects of microbial stimulation on the number, size and activity of bronchus-associated lymphoid tissue (BALT) structures in the pig. Int J Exp Pathol. 1992;73:351-357. LB.
200. Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 2000;68:1-8. LB.
201. Sue-Chu M, Karjalainen E-M, Laitinen A, Larsson L, Laitinen LA, Bjermer L. Placebo-controlled study of inhaled budesonide on indices of airways inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross country skiers. Respiration 2000;67:417-425. Ib.
202. Helenius I, Lumme A, Ounap J, et al. No effect of montelukast on asthma-like symptoms in elite ice hockey players. Allergy 2004;59:39-44. Ib.
203. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177:148-155. Ib.
204. Parsons JP, Mastronarde JG. Exercise-induced bronchoconstriction in athletes. Chest 2005;128:3966-3974. IV.
205. Bavarian B, Mehrkhani F, Ziaee V, Yousefi A, Nourian R. Sensitivity and specificity of self-reported symptoms for exercise-induced bronchospasm diagnosis in children. Iran J Pediatr. 2009;19:47-51. III.
206. Holzer K, Brukner P. Screening of athletes for exercise-induced bronchoconstriction. Clin J Sport Med. 2004;14:134-138. IV.
207. National Institutes of Health, Lung and Blood Institute. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. Bethesda, MD: Medical Communication Resources; 2007:16-19. http://www.ginasthma.org- ouverture dans une nouvelle fenêtre. Accessed October 16, 2010. IV.
208. Sano F, Sole D, Naspitz CK. Prevalence and characteristics of exercise-induced asthma in children. Pediatr Allergy Immunol. 1998;9:181-185. IIa.
209. Cabral ALB, Conceicao GM, Fonseca-Guedes CHF, Martins MA. Exercise-induced bronchospasm in children: effects of asthma severity. Am J Respir Crit Care Med. 1999;159:1819-1823. IIb.
210. Burr ML, Eldridge BA, Borysiewicz LK. Peak expiratory flow rates before and after exercise in schoolchildren. Arch Dis Child. 1974;49:923-926. IIa.
211. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child. 1989;64:1452-1456. IIa.
212. Mannix ET, Roberts M, Fagin DP, Reid B, Farber MO. The prevalence of airways hyperresponsiveness in members of an exercise training facility. J Asthma 2003;40:349-355. IIb.
213. Mannix ET, Roberts MA, Dukes HJ, Magnes CJ, Farber MO. Airways hyperresponsiveness in high school athletes. J Asthma 2004;41:567-574. IIb.
214. Rupp NT, Guill MF, Brudno DS. Unrecognized exercise-induced bronchospasm in adolescent athletes. Am J Dis Child. 1992;146:941-944. IIa.
215. Sudhir P, Prasad CE. Prevalence of exercise-induced bronchospasm in schoolchildren: an urban-rural comparison. J Trop Pediatr. 2003;49:104-108. IIa.
216. Hallstrand TS, Curtis JR, Koepsell TD, et al. Effectiveness of screening examinations to detect unrecognised exercise-induced bronchoconstriction. J Pediatr. 2002;141:343-348. IV.
217. Godfrey S, Konig P. Exercise-induced bronchial lability in wheezy children and their families. Pediatrics 1975;56(5 pt, suppl 2):851-855. IIa.
218. Daga MK, Ahuja VM, Bajaj SK, et al. Bronchial responsiveness in normal first-degree relatives of asthmatics and patients of allergic rhinitis. J Indian Acad Clin Med. 2007;8:36-41. IIa.
219. Sallaoui R, Chamari K, Mossa A, et al. Exercise-induced bronchoconstriction and atopy in Tunisian athletes. BMC Pulm Med. 2009;9:8. IIa.
220. Brutsche M, Britschgi D, Dayer E, Tschopp JM. Exercise-induced bronchospasm (EIB) in relation to seasonal and perennial specific IgE in young adults. Allergy 1995;50:905-909. IIa.
221. Gani F, Passalacqua G, Senna G, Mosca Frezet M. Sport, immune system and respiratory infections. Eur Ann Allergy Clin Immunol. 2003;35:41-46. IV.
222. Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol. 1998;102:722-726. III.
223. Weiler JM, Ryan EJ 3rd. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol. 2000;106:267-271. III.
224. Anderson SD, Connolly N, Godfrey S. Comparison of bronchoconstriction induced by cycling and running. Thorax 1971;26:396-401. IIa.
225. Fitch KD, Morton AR. Specificity of exercise in exercise-induced asthma. Br Med J. 1971;4:577-581. IIa.
226. Rundell KW, Wilber RL, Szmedra L, Jenkinson DM, Mayers LB, Im J. Exercise-induced asthma screening of elite athletes: field versus laboratory exercise challenge. Med Sci Sports Exerc. 2000;32:309-316. III.
227. Sue-Chu M, Larsson L, Moen T, Rennard SI, Bjermer L. Bronchoscopy and bronchoalveolar lavage findings in cross-country skiers with and without "ski asthma.". Eur Respir J. 1999;13:626-632. IIa.
228. Pohjantahti H, Laitinen J, Parkkari J. Exercise-induced bronchospasm among healthy elite cross country skiers and non-athletic students. Scand J Med Sci Sports 2005;15:324-328. IIa.
229. Randolph CC, Dreyfus D, Rundell KW, Bangladore D, Fraser B. Prevalence of allergy and asthma symptoms in recreational roadrunners. Med Sci Sports Exerc. 2006;38:2053-2057. III.
230. Rundell KW, Spiering BA, Judelson DA, Wilson MH. Bronchoconstriction during cross-country skiing: is there really a refractory period?. Med Sci Sports Exerc. 2003;35:18-26. IV.
231. Helenius I, Haahtela T. Allergy and asthma in elite summer sport athletes. J Allergy Clin Immunol. 2000;106:444-452. IV.
232. Bernard A, Nickmilder M, Voisin C, Sardella A. Impact of chlorinated swimming pool attendance on the respiratory health of adolescents. Pediatrics 2009;124:1110-1118. IIa.
233. Ucok K, Dane S, Gokbel H, Akar S. Prevalence of exercise-induced bronchospasm in long distance runners trained in cold weather. Lung 2004;182:265-270. IIa.
234. Rupp NT, Brudno S, Guill MF. The value of screening for risk of exercise-induced asthma in high school athletes. Ann Allergy 1993;70:339-342. IIb.
235. Sue-Chu M, Henriksen AH, Bjermer L. Non-invasive evaluation of lower airway inflammation in hyper-responsive elite cross-country skiers and asthmatics. Respir Med. 1999;93:719-725. IIa.
236. Castricum A, Holzer K, Brukner P, Irving L. The role of bronchial provocation challenge tests in the diagnosis of exercise-induced bronchoconstriction in elite swimmers. Br J Sports Med. 2010;44:736-740. IIb.
237. De Baets F, Bodart E, Dramaix-Wilmet M, et al. Exercise-induced respiratory symptoms are poor predictors of bronchoconstriction. Pediatr Pulmonol. 2005;39:301-305. IIb.
238. Schatz M, Clark S, Emond JA, Schreiber D, Camargo CA Jr. Sex differences among children 2-13 years of age presenting at the emergency department with acute asthma. Pediatr Pulmonol. 2004;37:523-529. III.
239. Lin RY, Lee GB. The gender disparity in adult asthma hospitalizations dynamically relates to age. J Asthma 2008;45:931-935. III.
240. Bardagi S, Agudo A, Gonzalez CA, Romero PV. Prevalence of exercise-induced airway narrowing in schoolchildren from a Mediterranean town. Am Rev Respir Dis. 1993;147:1112-1115. IIb.
241. Langdeau JB, Day A, Turcotte H, Boulet LP. Gender differences in the prevalence of airway hyperresponsiveness and asthma in athletes. Respir Med. 2009;103:401-406. III.
242. Keeley DJ, Neill P, Gallivan S. Comparison of the prevalence of reversible airways obstruction in rural and urban Zimbabwean children. Thorax 1991;46:549-553. IIa.
243. Kukafka DS, Lang DM, Porter S, et al. Exercise-induced bronchospasm in high school athletes via a free running test: incidence and epidemiology. Chest 1998;114:1613-1622. IIa.
244. Jones CO, Qureshi S, Rona RJ, Chinn S. Exercise-induced bronchoconstriction by ethnicity and presence of asthma in British nine year olds. Thorax 1996;51:1134-1136. III.
245. Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161:2086-2091. IIa.
246. Henriksen AH, Tveit KH, Holmen TL, Sue-Chu M, Bjermer L. A study of the association between exercise-induced wheeze and exercise versus methacholine-induced bronchoconstriction in adolescents. Pediatr Allergy Immunol. 2002;13:203-208. III.
247. Brannan JD, Koskela H, Anderson SD, Chew N. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med. 1998;158:1120-1126. III.
248. Evans TM, Rundell KW, Beck KC, Levine AM, Baumann JM. Airway narrowing measured by spirometry and impulse oscillometry following room temperature and cold temperature exercise. Chest 2005;128:2412-2419. III.
249. Evans TM, Rundell KW, Beck KC, Levine AM, Baumann JM. Cold air inhalation does not affect the severity of EIB after exercise or eucapnic voluntary hyperventilation. Med Sci Sports Exerc. 2005;37:544-549. III.
250. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest 2003;123:468-474. IIb.
251. Newman KB, Mason UG 3rd, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995;152(4 pt 1):1382-1386. IV.
252. Godfrey S, Silverman M, Anderson SD. The use of the treadmill for assessing exercise-induced asthma and the effect of varying the severity and the duration of exercise. Pediatrics 1975;56(5, pt 2 suppl):893-898. IV.
253. Haby MM, Anderson SD, Peat JK, Mellis CM, Toelle BG, Woolcock AJ. An exercise challenge protocol for epidemiological studies of asthma in children: comparison with histamine challenge. Eur Respir J. 1994;7:43-49. III.
254. [No authors listed]. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. Eur Respir J. 1997;10:2662-2689. IV.
255. Anderson SD, Silverman M, Konig P, Godfrey S. Exercise-induced asthma. Brit J Dis Chest 1975;69:1-39. IIa.
256. Eggleston PA, Rosenthal RR, Anderson SA, et al. Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy. J Allergy Clin Immunol. 1979;64:642-645. IV.
257. Konig P. Exercise challenge: indications and techniques. Allergy Proc. 1989;10:345-348. IV.
258. Mahler DA. Exercise-induced asthma. Med Sci Sports Exerc. 1993;25:554-561. IV.
259. Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001;37:153-156. IV.
260. Warren JB, Jennings SJ, Clark TJ. Effect of adrenergic and vagal blockade on the normal human airway response to exercise. Clin Sci (Lond) 1984;66:79-85. IV.
261. Zeitoun M, Wilk B, Matsuzaka A, KnOpfli BH, Wilson BA, Bar-Or O. Facial cooling enhances exercise-induced bronchoconstriction in asthmatic children. Med Sci Sports Exerc. 2004;36:767-771. IIb.
262. Koskela H, Tukiainen H. Facial cooling, but not nasal breathing of cold air, induces bronchoconstriction: a study in asthmatic and healthy subjects. Eur Respir J. 1995;8:2088-2093. IIa.
263. Miyazoe H, Harada Y, Yamasaki S, Tsuji Y. Clinical study on accentuated antagonism in the regulation of heart rate in children. Jpn Heart J. 1998;39:481-487. IIb.
264. Ogston J, Butcher JD. A sport-specific protocol for diagnosing exercise-induced asthma in cross-country skiers. Clin J Sport Med. 2002;12:291-295. III.
265. Souza AC, Pereira CA. [Bronchial provocation tests using methacholine, cycle ergometer exercise and free running in children with intermittent asthma.] [Article in Portuguese]. J Pediatr (Rio J) 2005;81:65-72. IV.
266. Stensrud T, Berntsen S, Carlsen KH. Humidity influences exercise capacity in subjects with exercise-induced bronchoconstriction (EIB). Respir Med. 2006;100:1633-1641. III.
267. Spiering BA, Judelson DA, Rundell KW. An evaluation of standardizing target ventilation for eucapnic voluntary hyperventilation using FEV1. J Asthma 2004;41:745-749. III.
268. Silverman M, Anderson SD. Metabolic cost of treadmill exercise in children. J Appl Physiol. 1972;33:696-698. IV.
269. Givoni B, Goldman RF. Predicting metabolic energy cost. J Appl Physiol. 1971;30:429-433. IV.
270. Jones NL. Clinical Exercise Testing. 4th ed. Philadelphia, PA: WB Saunders Company; 1997. IV.
271. Anderson SD, Lambert S, Brannan JD, et al. Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices. Med Sci Sports Exerc. 2001;33:893-900. IV.
272. Powers SK, Martin D, Cicale M, Collop N, Huang D, Criswell D. Exercise-induced hypoxemia in athletes: role of inadequate hyperventilation. Eur J Appl Physiol Occup Physiol. 1992;65:37-42. IV.
273. Roach JM, Hurwitz KM, Argyros GJ, Eliasson AH, Phillips YY. Eucapnic voluntary hyperventilation as a bronchoprovocation technique. Comparison with methacholine inhalation in asthmatics. Chest 1994;105:667-672. IV.
274. Anderson SD, Argyros GJ, Magnussen H, Holzer K. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med. 2001;35:344-347. III.
275. Sterling GM. The mechanism of bronchoconstriction due to hypocapnia in man. Clin Sci. 1968;34:277-285. IV.
276. Suman OE, Beck KC, Babcock MA, Pegelow DF, Reddan AW. Airway obstruction during exercise and isocapnic hyperventilation in asthmatic subjects. J Appl Physiol. 1999;87:1107-1113. IV.
277. Argyros GJ, Roach JM, Hurwitz KM, Eliasson AH, Phillips YY. The refractory period after eucapnic voluntary hyperventilation challenge and its effect on challenge technique. Chest 1995;108:419-424. IV.
278. Finnerty JP, Wilmont C, Holgate ST. Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Evidence for the predominant role of histamine. Am Rev Respir Dis. 1989;140:593-597. III.
279. Riedler J, Reade T, Dalton M, Holst D, Robertson C. Hypertonic saline challenge in an epidemiologic survey of asthma in children. Am J Respir Crit Care Med. 1994;150:1632-1639. III.
280. Rabone SJ, Phoon WO, Anderson SD, et al. Hypertonic saline challenge in an adult epidemiological survey. Occup Med. (Lond) 1996;46:177-185. III.
281. Smith CM, Anderson SD. A comparison between the airway response to isocapnic hyperventilation and hypertonic saline in subjects with asthma. Eur Respir J. 1989;2:36-43. IIb.
282. Belcher NG, Murdoch RD, Dalton N, et al. A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthma. Am Rev Respir Dis. 1988;137:1026-1032. IIb.
283. Anderson SD, Brannan JD, Chan HK. Use of aerosols for bronchial provocation testing in the laboratory: where we have been and where we are going. J Aerosol Med. 2002;15:313-324. IV.
284. Anderson SD, Brannan JD. Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea and hypertonic aerosols. Clin Rev Allergy Immunol. 2003;24:27-54. IV.
285. Jones SL, Herbison P, Cowan JO, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J. 2002;20:601-608. III.
286. Riedler J, Gamper A, Eder W, Oberfeld G. Prevalence of bronchial hyperresponsiveness to 4.5% saline and its relation to asthma and allergy symptoms in Austrian children. Eur Respir J. 1998;11:355-360. III.
287. Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res. 2005;6:144. IIb.
288. Anderson SD, Brannan J, Trevillion L, Young IH. Lung function and bronchial provocation testing for intending divers with a history of asthma. SPUMS J 1995;25:233-248. IV.
289. Anderson SD. Challenge tests to assess airway hyperresponsiveness and efficacy of drugs used in the treatment of asthma. J Aerosol Med. 1996;9:95-109. IV.
290. Anderson SD, Brannan J, Spring J, et al. A new method for bronchial provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med. 1997;156:758-765. III.
291. Munoz PA, Gomez FP, Manrique HA, et al. Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma. J Appl Physiol. 2008;105:1477-1485. IV.
292. Holzer K, Anderson SD, Chan HK, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003 15;167:534-537. IV.
293. Cowan DC, Hewitt RS, Cowan JO, et al. Exercise-induced wheeze: fraction of exhaled nitric oxide-directed management. Respirology 2010;15:683-690. IV.
294. Brannan JD, Koskela H, Anderson SD, Chan HK. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002;7:37-44. IIb.
295. International Olympic Medical Committee. [beta]2-adrenoceptor agonists and the Olympic Games in Beijing. 2008. Available at http://multimedia.olympic.org/pd...- ouverture dans une nouvelle fenêtre. Accessed October 16, 2010. IV.
296. Dickinson JW, Whyte GP, McConnell AK, Harries MG. Screening elite winter athletes for exercise induced asthma: a comparison of three challenge methods. Br J Sports Med. 2006;40:179-182. IV.
297. Christopher KL, Wood RP 2nd, Eckert RC, Blager FB, Raney RA, Souhrada JF. Vocal-cord dysfunction presenting as asthma. N Engl J Med. 1983;308:1566-1570. IIb.
298. Bjornsdottir US, Gudmundsson K, Hjartarson H, Brondbo K, Magnusson B, Juliusson S. Exercise-induced laryngochalasia: an imitator of exercise-induced bronchospasm. Ann Allergy Asthma Immunol. 2000;85:387-391. III.
299. Chemery L, Le Clech G, Delaval P, Carre F, Gogibu J, Dassonville J. [Exercise-induced laryngomalacia] [Article in French]. Rev Mal Respir. 2002;19(5 pt 1):641-643. III.
300. Bittleman DB, Smith RJ, Weiler JM. Abnormal movement of the arytenoid region during exercise presenting as exercise-induced asthma in an adolescent athlete. Chest 1994;106:615-616. III.
301. McFadden ER Jr, Zawadski DK. Vocal cord dysfunction masquerading as exercise-induced asthma. A physiologic cause for "choking" during athletic activities. Am J Respir Crit Care Med. 1996;153:942-947. IIb.
302. Morris MJ, Deal LE, Bean DR, Grbach VX, Morgan JA. Vocal cord dysfunction in patients with exertional dyspnea. Chest 1999;116:1676-1682. IIa.
303. Perkins PJ, Morris MJ. Vocal cord dysfunction induced by methacholine challenge testing. Chest 2002;122:1988-1993. IIa.
304. Davis RS, Brugman SM, Larsen GL. Use of videography in the diagnosis of exercise-induced vocal cord dysfunction: a case report with video clips. J Allergy Clin Immunol. 2007;119:1329-1331. III.
305. Heimdal JH, Roksund OD, Halvorsen T, Skadberg BT, Olofsson J. Continuous laryngoscopy exercise test: a method for visualizing laryngeal dysfunction during exercise. Laryngoscope 2006;116:52-57. III.
306. Fahey JT, Bryant NJ, Karas D, Goldberg B, Destefano R, Gracco LC. Exercise-induced stridor due to abnormal movement of the arytenoids area: videoendoscopic diagnosis and characterization of the "at risk" group. Pediatr Pulmonol. 2005;39:51-55. III.
307. Richter GT, Rutter MJ, deAlarcon A, Orvidas LJ, Thompson DM. Late-onset laryngomalacia: a variant of disease. Arch Otolaryngol Head Neck Surg. 2008;134:75-80. IIb.
308. Bent JP 3rd, Miller DA, Kim JW, Bauman NM, Wilson JS, Smith RJ. Pediatric exercise-induced laryngomalacia. Ann Otol Rhinol Laryngol. 1996;105:169-175. III.
309. Mandell DL, Arjmand EM. Laryngomalacia induced by exercise in a pediatric patient. Int J Pediatr Otorhinolaryngol. 2003;67:999-1003. III.
310. Smith RJ, Bauman NM, Bent JP, Kramer M, Smits WL, Ahrens RC. Exercise-induced laryngomalacia. Ann Otol Rhinol Laryngol. 1995;104:537-541. IV.
311. Lakin RC, Metzger WJ, Haughey BH. Upper airway obstruction presenting as exercise-induced asthma. Chest 1984;86:499-501. III.
312. Gessler EM, Simko EJ, Greinwald JH Jr. Adult laryngomalacia: an uncommon clinical entity. Am J Otolaryngol. 2002;23:386-389. III.
313. Patel NJ, Jorgensen C, Kuhn J, Merati AL. Concurrent laryngeal abnormalities in patients with paradoxical vocal fold dysfunction. Otolaryngol Head Neck Surg. 2004;130:686-689. IIb.
314. Powell DM, Karanfilov BI, Beechler KB, Treole K, Trudeau MD, Forrest LA. Paradoxical vocal cord dysfunction in juveniles. Arch Otolaryngol Head Neck Surg. 2000;126:29-34. IIb.
315. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1534-1540. IV.
316. Hammo AH, Weinberger MM. Exercise-induced hyperventilation: a pseudoasthma syndrome. Ann Allergy Asthma Immunol. 1999;82:574-578. III.
317. Weinberger MM. Etiology of exercise-induced dyspnea: not just exercise-induced asthma or vocal cord dysfunction. J Allergy Clin Immunol. 2008;121:269. IV.
318. Weinberger M, Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics 2007;120:855-864. III.
319. Weinberger M. Exercise induced dyspnoea: if not asthma, then what?. Arch Dis Child. 2006;91:543-544. III.
320. Meyer T, Faude O, Scharhag J, Urhausen A, Kindermann W. Is lactic acidosis a cause of exercise induced hyperventilation at the respiratory compensation point?. Br J Sports Med. 2004;38:622-625. III.
321. White KM, Quinn JM, Hagan LL, Johnson TL 2nd. Exercise-induced hyperventilation. Ann Allergy Asthma Immunol. 2008;100:171-172. III.
322. Jack S, Rossiter HB, Pearson MG, Ward SA, Warburton CJ, Whipp BJ. Ventilatory responses to inhaled carbon dioxide, hypoxia, and exercise in idiopathic hyperventilation. Am J Respir Crit Care Med. 2004;170:118-125. IIa.
323. Lopes WA, Radominski RB, Rosario Filho NA, Leite N. Exercise induced bronchospasm in obese adolescents. Allergol Immunopathol (Madr). 2009;37:175-179. IIa.
324. Fonkalsrud EW, DeUgarte D, Choi E. Repair of pectus excavatum and carinatum deformities in 116 adults. Ann Surg. 2002;236:304-312. III.
325. Koumbourlis AC, Stolar CJ. Lung growth and function in children and adolescents with idiopathic pectus excavatum. Pediatr Pulmonol. 2004;38:339-343. III.
326. Smyth RJ, Chapman KR, Wright TA, Crawford JS, Rebuck AS. Ventilatory patterns during hypoxia, hypercapnia, and exercise in adolescents with mild scoliosis. Pediatrics 1986;77:692-697. III.
327. Ben-Dov I, Kaminski N, Reichert N, Rosenman J, Shulimzon T. Diaphragmatic paralysis: a clinical imitator of cardiorespiratory diseases. Isr Med Assoc J. 2008;10(8-9):579-583. III.
328. Marciniuk DD, Sridhar G, Clemens RE, Zintel TA, Gallagher CG. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease. J Appl Physiol. 1994;77:963-973. III.
329. Harris-Eze AO, Sridhar G, Clemens RE, Zintel TA, Gallagher CG, Marciniuk DD. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease. Am J Respir Crit Care Med. 1996;154(4 pt 1):994-1001. III.
330. Sheffer AL, Austen KF. Exercise-induced anaphylaxis. J Allergy Clin Immunol. 1980;66:106-111. III.
331. Sheffer AL, Austen KF. Exercise-induced anaphylaxis. J Allergy Clin Immunol. 1984;73(5 pt 2):699-703. IV.
332. Maulitz RM, Pratt DS, Schocket AL. Exercise-induced anaphylactic reaction to shellfish. J Allergy Clin Immunol. 1979;63:433-434. III.
333. Kidd JM 3rd, Cohen SH, Sosman AJ, Fink JN. Food-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol. 1983;71:407-411. III.
334. Kivity S, Sneh E, Greif J, Topilsky M, Mekori YA. The effect of food and exercise on the skin response to compound 48/80 in patients with food-associated exercise-induced urticaria-angioedema. J Allergy Clin Immunol. 1988;81:1155-1158. III.
335. Schwartz HJ. Elevated serum tryptase in exercise-induced anaphylaxis. J Allergy Clin Immunol. 1995;95:917-919. III.
336. Du Toit G. Food-dependent exercise-induced anaphylaxis in childhood. Pediatr Allergy Immunol. 2007;18:455-463. IV.
337. Palosuo K, Alenius H, Varjonen E, et al. A novel wheat gliadin as a cause of exercise-induced anaphylaxis. J Allergy Clin Immunol. 1999;103(5 pt 1):912-917. IIb.
338. Palosuo K, Varjonen E, Nurkkala J, et al. Transglutaminase-mediated cross-linking of a peptic fraction of omega-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. J Allergy Clin Immunol. 2003;111:1386-1392. IIb.
339. Matsuo H, Kohno K, Niihara H, Morita E. Specific IgE determination to epitope peptides of omega-5 gliadin and high molecular weight glutenin subunit is a useful tool for diagnosis of wheat-dependent exercise-induced anaphylaxis. J Immunol. 2005;175:8116-8122. IIb.
340. Matsuo HDahlstrom J, Tanaka A, et al. Sensitivity and specificity of recombinant omega-5 gliadin-specific IgE measurement for the diagnosis of wheat-dependent exercise-induced anaphylaxis. Allergy 2008;63:233-236. IIa.
341. Oyefara BI, Bahna SL. Delayed food-dependent, exercise-induced anaphylaxis. Allergy Asthma Proc. 2007;28:64-66. III.
342. Meyer FJ, Ewert R, Hoeper MM, et al. Peripheral airway obstruction in primary pulmonary hypertension. Thorax 2002;57:473-476. IIa.
343. D'Alonzo GE, Gianotti LA, Pohil RL, et al. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest 1987;92:57-62. IIa.
344. Rastogi D, Ngai P, Barst RJ, Koumbourlis AC. Lower airway obstruction, bronchial hyperresponsiveness, and primary pulmonary hypertension in children. Pediatr Pulmonol. 2004;37:50-55. IIb.
345. Achouh L, Montani D, Garcia G, et al. Pulmonary arterial hypertension masquerading as severe refractory asthma. Eur Respir J. 2008;32:513-516. III.
346. Reindl I, Kleber FX. Exertional hyperpnea in patients with chronic heart failure is a reversible cause of exercise intolerance. Basic Res Cardiol. 1996;91(suppl 1):37-43. IIb.
347. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-1320. IV.
348. Frank MJ, Abdulla AM, Watkins LO, Prisant L, Stefadouros MA. Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol. Eur Heart J. 1983;4(suppl F):155-164. IIb.
349. Besley DC, McWilliams GJ, Moodie DS, Castle LW. Long-term follow-up of young adults following permanent pacemaker placement for complete heart block. Am Heart J. 1982;103:332-337. III.
350. Parker JM, Cary-Freitas B, Berg BW. Symptomatic vascular rings in adulthood: an uncommon mimic of asthma. J Asthma 2000;37:275-280. III.
351. Chuang ML, Chang HC, Lim KE, Vintch JR. Gas exchange detection of right-to-left shunt in dyspneic patients: report of three cases. Int J Cardiol. 2006;108:117-119. III.
352. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. 1998;158:643-661. IV.
353. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:622-629. IIa.
354. Dempsey JA, McKenzie DC, Haverkamp HC, Eldridge MW. Update in the understanding of respiratory limitations to exercise performance in fit, active adults. Chest 2008;134:613-622. IV.
355. Ferrari M, Bonella F, Benini L, et al. Acid reflux into the oesophagus does not influence exercise-induced airway narrowing in bronchial asthma. Br J Sports Med. 2008;42:845-849. IIb.
356. Weiner P, Konson N, Sternberg A, Zamir D, Fireman Z. Is gastrooesophageal reflux a factor in exercise-induced asthma?. Respir Med. 1998;92:1071-1075. IIa.
357. Wright RA, Sagatelian MA, Simons ME, McClave SA, Roy TM. Exercise-induced asthma. Is gastroesophageal reflux a factor?. Dig Dis Sci. 1996;41:921-925. IIb.
358. Peterson KA, Samuelson WM, Ryujin DT, et al. The role of gastroesophageal reflux in exercise-triggered asthma: a randomized controlled trial. Dig Dis Sci. 2009;54:564-571. Ib.
359. Peters HP, De Kort AF, Van Krevelen H, et al. The effect of omeprazole on gastro-oesophageal reflux and symptoms during strenuous exercise. Aliment Pharmacol Ther. 1999;13:1015-1022. Ib.
360. Haden JR, Khan DA. Psychiatric syndromes that mimic asthma. Adv Psychosom Med. 2003;24:72-85. IV.
361. Ringsberg KC, Akerlind I. Presence of hyperventilation in patients with asthma-like symptoms but negative asthma test responses: provocation with voluntary hyperventilation and mental stress. J Allergy Clin Immunol. 1999;103:601-608. IIa.
362. Babb TG, Ranasinghe KG, Comeau LA, Semon TL, Schwartz B. Dyspnea on exertion in obese women: association with an increased oxygen cost of breathing. Am J Respir Crit Care Med. 2008;178:116-123. IIb.
363. Davies CT, Godfrey S, Light M, Sargeant AJ, Zeidifard E. Cardiopulmonary responses to exercise in obese girls and young women. J Appl Physiol. 1975;38:373-376. III.
364. Haller RG, Lewis SF, Estabrook RW, DiMauro S, Servidei S, Foster DW. Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J Clin Invest. 1989;84:155-161. III.
365. Hooper RG, Thomas AR, Kearl RA. Mitochondrial enzyme deficiency causing exercise limitation in normal-appearing adults. Chest 1995;107:317-322. III.
366. Flaherty KR, Wald J, Weisman IM, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med. 2001;164:425-432. IIa.
367. Rossing TH, Weiss JW, Breslin FJ, Ingram RH Jr, McFadden ER Jr. Effects of inhaled sympathomimetics on obstructive response to respiratory heat loss. J Appl Physiol. 1982;52:1119-1123. Ib.
368. Latimer KM, O'Byrne PM, Morris MM, Roberts R, Hargreave FE. Bronchoconstriction stimulated by airway cooling. Better protection with combined inhalation of terbutaline sulphate and cromolyn sodium than with either alone. Am Rev Respir Dis. 1983;128:440-443. Ib.
369. Food and Drug Association: Center for Drug Evaluation and Research Draft Guidance for Industry. Exercise-induced bronchospasm (EIB). Development of drugs to prevent EIB. Draft Guidance. Washington, DC: US Dept of Health and Human Services; February 2002. IV.
370. Kemp JP, Dockhorn RJ, Shapiro GG, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr. 1998;133:424-428. Ib.
371. Anderson S, Seale JP, Ferris L, Schoeffel R, Lindsay DA. An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol. 1979;64(6 pt 2):612-624. IV.
372. Godfrey S, Konig P. Suppression of exercise-induced asthma by salbutamol, theophylline, atropine, cromolyn, and placebo in a group of asthmatic children. Pediatrics 1975;56:930-934. Ib.
373. Godfrey S, Konig P. Inhibition of exercise-induced asthma by different pharmacological pathways. Thorax 1976;31:137-143. Ib.
374. Hofstra WB, Sont JK, Sterk PJ, Neijens HJ, Kuethe MC, Duiverman EJ. Sample size estimation in studies monitoring exercise-induced bronchoconstriction in asthmatic children. Thorax 1997;52:739-741. IIa.
375. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. Eur Respir J. 1997 Nov;10:2662-2689. IV.
376. Anderson SD, Seale JP, Rozea P, Bandler L, Theobald G, Lindsay DA. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis. 1976;114:493-500. IIa.
377. McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med. 1994;330:1362-1367. IV.
378. Hendrickson CD, Lynch JM, Gleeson K. Exercise induced asthma: a clinical perspective. Lung 1994;172:1-14. IV.
379. Moraes TJ, Selvadurai H. Management of exercise-induced bronchospasm in children: the role of leukotriene antagonists. Treat Respir Med. 2004;3:9-15. IV.
380. Tan RA, Spector SL. Exercise-induced asthma: diagnosis and management. Ann Allergy Asthma Immunol. 2002;89:226-235. IV.
381. Kelly HW. What is new in the prevention of exercise-induced bronchospasm (EIB) in children?. Pediatr Asthma Allergy Immunol. 2008;21:40-43. IV.
382. Anderson SD, Caillaud C, Brannan JD. [beta]2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol. 2006;31(2-3):163-180. IV.
383. Peachell P. Regulation of mast cells by [beta]2-agonists. Clin Rev Allergy Immunol. 2006;31(2-3):131-142. IV.
384. Schoeffel RE, Anderson SD, Lindsay DA. Sodium cromoglycate as a pressurized aerosol (vicrom) in exercise-induced asthma. Aust N Z J Med. 1983;13:157-161. IIa.
385. Anderson SD, Rodwell LT, Du Toit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991;100:1254-1260. Ib.
386. Schoeffel RE, Anderson SD, Seale JP. The protective effect and duration of action of metaproteronol aerosol on exercise-induced asthma. Ann Allergy 1981;46:273-275. Ib.
387. Aebischer JC, Benoit RC, Scherrer M. [Pirbuterol and salbutamol aerosol for exercise-induced bronchoconstriction] [Article in German]. Schweiz Med Wochenschr. 1984;114:1660-1664. Ib.
388. Pearlman DS, Rees W, Schaefer K, Huang H, Andrews WT. An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. J Asthma 2007;44:729-733. Ib.
389. Ferrari M, Balestreri F, Baratieri S, Biasin C, Oldani V, Lo Cascio V. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma. Respiration 2000;67:510-513. Ib.
390. Ferrari M, Segattini C, Zanon R, et al. Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test. Respiration 2002;69:509-512. Ib.
391. Bisgaard H. Long-acting beta2-agonists in management of childhood asthma: a critical review of the literature. Pediatr Pulmonol. 2000;29:221-234. IV.
392. Kemp JP, Dockhorn RJ, Busse WW, Bleecker ER, Van As A. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med. 1994;150:1612-1615. Ib.
393. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER Jr. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med. 1998;339:141-146. Ib.
394. Carlsen KH, Roksund O, Olsholt K, Nja F, Leegaard J, Bratten G. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Eur Respir J. 1995;8:1852-1855. Ib.
395. Newnham DM, Ingram CG, Earnshaw J, Palmer JB, Dhillon DP. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma. Respir Med. 1993;87:439-444. Ib.
396. Boner AL, Spezia E, Piovesan P, Chiocca E, Maiocchi G. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med. 1994;149:935-939. Ib.
397. Vilsvik J, Ankerst J, Palmqvist M, et al. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis. Respir Med. 2001;95:484-490. Ib.
398. Bronsky EA, Yegen U, Yeh CM, Larsen LV, Della Cioppa G. Formoterol provides long lasting protection against exercise-induced bronchospasm. Ann Allergy Asthma Immunol. 2002;89:407-412. Ib.
399. Villaran C, O'Neill SJ, Helbling A, et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J Allergy Clin Immunol. 1999;104(3 Part 1):547-553. Ib.
400. Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med. 2000;132:97-104. Ib.
401. Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med. 2002;165:1068-1070. Ib.
402. Inman MD, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 1996;153:65-69. Ib.
403. Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR. Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J. 2003;21:810-815. Ib.
404. Hancox RJ, Aldridge RE, Cowan JO, et al. Tolerance to beta-agonists during acute bronchoconstriction. Eur Respir J. 1999;14:283-287. Ib.
405. Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Respir Med. 2000;94:767-771. Ib.
406. Haney S, Hancox RJ. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials. Respir Res. 2007;8:19. Ib.
407. Aziz I, Tan KS, Hall IP, Devlin MM, Lipworth BJ. Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol. Eur Respir J. 1998;12:580-584. Ib.
408. Drotar DE, Davis EE, Cockcroft DW. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Ann Allergy Asthma Immunol. 1998;80:31-34. Ib.
409. Bhagat R, Kalra S, Swystun VA, Cockcroft DW. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1995;108:1235-1239. Ib.
410. Davis BE, Reid JK, Cockcroft DW. Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection. Can Respir J. 2003;10:23-26. Ib.
411. Giannini D, Carletti A, Dente FL, et al. Tolerance to the protective effect of salmeterol on allergen challenge. Chest 1996;110:1452-1457. Ib.
412. Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med. 2004;98:1051-1062. Ib.
413. Garcia R, Guerra P, Feo F, et al. Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm. J Investig Allergol Clin Immunol. 2001;11:176-182. Ib.
414. Johnson M. Molecular mechanisms of [beta]2-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol. 2006;117:18-24. IV.
415. Hayes MJ, Qing F, Rhodes CG, et al. In vivo quantification of human pulmonary beta-adrenoceptors: effect of beta-agonist therapy. Am J Respir Crit Care Med. 1996;154:1277-1283. III.
416. McGraw DW, Liggett SB. Heterogeneity in beta-adrenergic receptor kinase expression in the lung accounts for cell-specific desensitization of the beta2-adrenergic receptor. J Biol Chem. 1997;272:7338-7344. IIa.
417. O'Connor BJ, Aikman SL, Barnes PJ. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med. 1992;327:1204-1208. Ib.
418. Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol. 2000;106:57-64. Ia.
419. Adler A, Uziel Y, Mei-Zahav M, Horowitz I. Formoterol induces tolerance to the bronchodilating effect of salbutamol following methacholine-provocation test in asthmatic children. Pulm Pharmacol Ther. 2006;19:281-285. Ia.
420. Anderson GP. Current issues with [beta]2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms. Clin Rev Allergy Immunol. 2006;31(2-3):119-130. IV.
421. Finnerty JP, Holgate ST. The contribution of histamine release and vagal reflexes, alone and in combination, to exercise-induced asthma. Eur Respir J. 1993;6:1132-1137. Ib.
422. Knopfli BH, Bar-Or O, Araujo CG. Effect of ipratropium bromide on EIB in children depends on vagal activity. Med Sci Sports Exerc. 2005;37:354-359. IIa.
423. Sarria B, Naline E, Zhang Y, et al. Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus. Am J Physiol Lung Cell Mol Physiol. 2002;283:L1125-L1132. IIa.
424. Taylor DR. The beta-agonist saga and its clinical relevance: on and on it goes. Am J Respir Crit Care Med. 2009;179:976-978. IV.
425. Hanania NA, Singh S, El-Wali R, et al. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008;21:134-141. IIa.
426. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996;109:953-956. Ib.
427. Food and Drug Association (FDA). FDA Drug Safety Communication: New safety requirements for long-acting inhaled asthma medications called Long-Acting Beta-Agonists (LABAs) 2010. http://www.fda.gov/Drugs/DrugSaf...- ouverture dans une nouvelle fenêtre. Accessed October 16, 2010. IV.
428. Meltzer SS, Hasday JD, Cohn J, Bleecker ER. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med. 1996;153:931-935. Ib.
429. Finnerty JP, Holgate ST. Evidence for the roles of histamine and prostaglandins as mediators in exercise-induced asthma: the inhibitory effect of terfenadine and flurbiprofen alone and in combination. Eur Respir J. 1990;3:540-547. Ib.
430. O'Byrne PM. Leukotriene bronchoconstriction induced by allergen and exercise. Am J Respir Crit Care Med. 2000;161(2 pt 2):S68-S72. IV.
431. Fogel RB, Rosario N, Aristizabal G, et al. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol. 2010;104:511-517. Ib.
432. O'Byrne PM. Initiation, dose reduction, and duration of inhaled corticosteroid therapy. Immunol Allergy Clin North Am. 2005;25:511-521. IV.
433. Smith LJ, Greenberger PA, Patterson R, Krell RD, Bernstein PR. The effect of inhaled leukotriene D4 in humans. Am Rev Respir Dis. 1985;131:368-372. IIa.
434. Finnerty JP, Wood-Baker R, Thomson H, Holgate ST. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am Rev Respir Dis. 1992;145:746-749. Ib.
435. Mastalerz L, Gawlewicz-Mroczka A, Nizankowska E, Cmiel A, Szczeklik A. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma. Clin Exp Allergy 2002;32:1360-1365. Ib.
436. Coreno A, Skowronski M, Kotaur C, McFadden ER Jr. Comparative effects of long-acting [beta]2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol. 2000;106:500-506. Ib.
437. Philip G, Villaran C, Pearlman DS, Loeys T, Dass SB, Reiss TF. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J Asthma 2007;44:213-217. Ib.
438. Philip G, Pearlman DS, Villaran C, et al. Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. Chest 2007;132:875-883. Ib.
439. Bronsky EA, Kemp JP, Zhang J, Guerreiro D, Reiss TF. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval. Clin Pharmacol Ther. 1997;62:556-561. Ib.
440. Peroni DG, Piacentini GL, Ress M, et al. Time efficacy of a single dose of montelukast on exercise-induced asthma in children. Pediatr Allergy Immunol. 2002;13:434-437. Ib.
441. de Benedictis FM, del Giudice MM, Forenza N, Decimo F, de Benedictis D, Capristo A. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur Respir J. 2006;28:291-295. Ib.
442. Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull. 2000;56:1054-1070. Ib.
443. Kim JH, Lee SY, Kim HB, et al. TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma. Clin Exp Allergy 2008;38:51-59. IIa.
444. Lehnigk B, Rabe KF, Dent G, Herst RS, Carpentier PJ, Magnussen H. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients. Eur Respir J. 1998;11:617-623. Ib.
445. Van Schoor J, Joos GF, Kips JC, Drajesk JF, Carpentier PJ, Pauwels RA. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med. 1997;155:875-880. Ib.
446. Manning PJ, Watson RM, Margolskee DJ, Williams VC, Schwartz JI, O'Byrne PM. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med. 1990;323:1736-1739. Ib.
447. Silverman M, Andrea T. Time course of effect of disodium cromoglycate on exercise-induced asthma. Arch Dis Child. 1972;47:419-422. Ib.
448. Woolley M, Anderson SD, Quigley BM. Duration of protective effect of terbutaline sulphate and cromolyn sodium alone and in combination on exercise-induced asthma. Chest 1990;97:39-45. Ib.
449. Comis A, Valletta EA, Sette L, Andreoli A, Boner AL. Comparison of nedocromil sodium and sodium cromoglycate administered by pressurized aerosol, with and without a spacer device in exercise-induced asthma in children. Eur Respir J. 1993;6:523-526. Ib.
450. de Benedictis FM, Tuteri G, Pazzelli P, Solinas LF, Niccoli A, Parente C. Combination drug therapy for the prevention of exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol. 1998;80:352-356. Ib.
451. Patel KR, Wall RT. Dose-duration effect of sodium cromoglycate aerosol in exercise-induced asthma. Eur J Respir Dis. 1986;69:256-260. Ib.
452. Patel KR, Tullett WM, Neale MG, Wall RT, Tan KM. Plasma concentrations of sodium cromoglycate given by nebulisation and metered dose inhalers in patients with exercise-induced asthma: relationship to protective effect. Br J Clin Pharmacol. 1986;21:231-233. Ib.
453. Kuzemko JA. Twenty years of sodium cromoglycate treatment: a short review. Respir Med. 1989;83:11-14. IV.
454. Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth-breathing, and asthma. Am Rev Respir Dis. 1984;130:1014-1018. Ib.
455. Henriksen JM. Effect of inhalation of corticosteroids on exercise induced asthma: randomised double blind crossover study of budesonide in asthmatic children. Br Med J (Clin Res Ed) 1985;291:248-249. Ib.
456. Yates DH, Kharitonov S, Barnes PJ. An inhaled glucocorticoid does not prevent tolerance to the protective effect of a long-acting inhaled beta 2-agonist. Am J Respir Crit Care Med. 1996;154:1603-1607. Ib.
457. Blake K. Review of guidelines and the literature in the treatment of acute bronchospasm in asthma. Pharmacotherapy 2006;26(9 pt 2):148S-155S. IV.
458. Beil M, de Kock MA. Role of alpha-adrenergic receptors in exercise-induced bronchoconstriction. Respiration 1978;35:78-86. IIa.
459. Boulet L-P, Turcotte H, Tennina S. Comparative efficacy of salbutamol, ipratropium and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges. J Allergy Clin Immunol. 1989;83:882-887. Ib.
460. Poppius H, Sovijarvi ARA, Tammilehto L. Lack of protective effect of high-dose ipratropium on bronchoconstriction following exercise with cold air breathing in patients with mild asthma. Eur J Respir Dis. 1986;68:319-325. Ib.
461. Magnussen H, Nowak D, Wiebicke W. Effect of inhaled ipratropium bromide on the airway response to methacholine, histamine, and exercise in patients with mild bronchial asthma. Respiration 1992;59:42-47. Ib.
462. Boner AL, Vallone G, De Stefano G. Effect of inhaled ipratropium bromide on methacholine and exercise provocation in asthmatic children. Pediatr Pulmonol. 1989;6:81-85. Ib.
463. Ellis EF. Inhibition of exercise-induced asthma by theophylline. J Allergy Clin Immunol. 1984;73(5 pt 2):690-692. IV.
464. Iikura Y, Hashimoto K, Akasawa A, et al. Serum theophylline concentration levels and preventative effects on exercise-induced asthma. Clin Exp Allergy 1996;26(suppl 2):38-41. IIa.
465. Seale JP, Anderson SD, Lindsay DA. A comparison of oral theophylline and oral salbutamol in exercise-induced asthma. Aust N Z J Med. 1977;7:270-274. IIa.
466. Timmer W, Leclerc V, Birraux G, et al. The phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-[alpha] ex vivo. J Clin Pharmacol. 2002;42:297-303. Ib.
467. Clee MD, Ingram CG, Reid PC, Robertson AS. The effect of astemizole on exercise-induced asthma. Br J Dis Chest 1984;78:180-183. IIa.
468. Magnussen H, Reuss G, Jorres R, Aurich R. The effect of azelastine on exercise-induced asthma. Chest 1988;93:937-940. Ib.
469. Wiebicke W, Poynter A, Montgomery M, Chernick V, Pasterkamp H. Effect of terfenadine on the response to exercise and cold air in asthma. Pediatr Pulmonol. 1988;4:225-229. Ib.
470. Zielinski J, Chodosowska E. Exercise-induced bronchoconstriction in patients with bronchial asthma. Its prevention with an antihistaminic agent. Respiration 1977;34:31-35. IIa.
471. Peroni DG, Piacentini GL, Pietrobelli A, et al. The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children. Eur Respir J. 2002;20:104-107. Ib.
472. Manjra AI, Nel H, Maharaj B. Effect of desloratadine on patients with allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study. J Asthma 2009;46:156-159. Ib.
473. Passalacqua G, Canonica GW, Bousquet J. Structure and classification of H1-antihistamines and overview of their activities. Clin Allergy Immunol. 2002;17:65-100. IV.
474. Ghosh SK, De Vos C, McIlroy I, Patel KR. Effect of cetirizine on exercise induced asthma. Thorax 1991;46:242-244. Ib.
475. Barnes PJ, Wilson NM, Brown MJ. A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax 1981;36:726-730. Ib.
476. Corris PA, Nariman S, Gibson GJ. Nifedipine in the prevention of asthma induced by exercise and histamine. Am Rev Respir Dis. 1983;128:991-992. Ib.
477. Lockhart A, Slutsky AS. Furosemide and loop diuretics in human asthma. Chest 1994;106:244-249. IV.
478. Prandota J. Furosemide: progress in understanding its diuretic, antiinflammatory, and bronchodilating mechanism of action, and use in the treatment of respiratory tract diseases. Am J Ther. 2002;9:317-328. IV.
479. Bianco S, Vaghi A, Robuschi M, Pasargiklian M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet 1988;2:252-255. Ib.
480. Barnes PJ, Wilson NM, Vickers H. Prazosin, an alpha 1-adrenoceptor antagonist, partially inhibits exercise-induced asthma. J Allergy Clin Immunol. 1981;68:411-415. Ib.
481. Ahmed T, Gonzalez BJ, Danta I. Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin. Am J Respir Crit Care Med. 1999;160:576-581. Ib.
482. Kunz LI, van Rensen EL, Sterk PJ. Inhaled hyaluronic acid against exercise-induced bronchoconstriction in asthma. Pulm Pharmacol Ther. 2006;19:286-291. Ib.
483. McKenzie DC, McLuckie SL, Stirling DR. The protective effects of continuous and interval exercise in athletes with exercise-induced asthma. Med Sci Sports Exerc. 1994;26:951-956. Ib.
484. Mickleborough TD, Lindley MR, Turner LA. Comparative effects of a high-intensity interval warm-up and salbutamol on the bronchoconstrictor response to exercise in asthmatic athletes. Int J Sports Med. 2007;28:456-462. Ib.
485. Mickleborough TD, Fogarty A. Dietary sodium intake and asthma: an epidemiological and clinical review. Int J Clin Pract. 2006;60:1616-1624. Ib.
486. Mickleborough TD, Lindley MR. Diet and exercise-induced bronchoconstriction. Chest 2006;130:623-624. Ib.
487. Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007;101:1770-1778. Ib.
488. Anderson SD, Pearlman DS, Rundell KW, Perry CP, Boushey H, Sorkness CA, Nichols S, Weiler JM. Reproducibility of the airway response to an exercise protocol standardized for intensity, duration, and inspired air conditions, in subjects with symptoms suggestive of asthma. Respir Res. 2010 Sep 1;11:120. IIb.
489. Clearie KL, Williamson PA, Vaidyanathan S, et al. Disconnect between standardized field-based testing and mannitol challenge in Scottish elite swimmers. Clin Exp Allergy 2010 May;40:731-737. IIb.
490. O'Byrne PM, Gauvreau GM, Brannan JD. Provoked models of asthma: what have we learnt?. Clin Exp Allergy 2009;39:181-192. IV.
491. National Asthma Education and Prevention Program. Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, US Dept of Health and Human Services, National Institutes of Health; 2007. NIH publication 07-4051. IV.
492. Bougault V, Turmel J, Boulet LP. Bronchial challenges and respiratory symptoms in elite swimmers and winter sport athletes. Chest 2010;138(suppl 2):31S-37S. IIb.
493. Hull JH, Hull PJ, Parsons JP, Dickinson JW, Ansley L. Approach to the diagnosis and management of suspected exercise-induced bronchoconstriction by primary care physicians. BMC Pulm Med. 2009;9:29. IV.
|
Language: | English.
|
Document Type: | Practice parameter.
|
Journal Subset: | Clinical Medicine. Life & Biomedical Sciences.
|
ISSN: | 1081-1206
|
NLM Journal Code: | cbm, 9503580
|
Annotation(s) | |
|
|